LONG-TERM RESULTS OF STAGE MYOCARDIAL REVASCULARIZATION IN PATIENTS WITH ACUTE CORONARY SYNDROME AND MULTIVESSEL LESION
Abstract
Aim. To study long-term results of coronary artery bypass grafting in patients with acute coronary syndrome and multivessel lesion. Material and methods. The work analyses two-year treatment observation results of patients with acute coronary syndrome and multivessel coronary artery disease, who underwent stenting of a clinically dependent artery for emergency indications, and coronary artery bypass grafting in a period of up to 90 days. The efficacy and safety were assessed according to the criteria of “non-inferiority " in comparison with the literature data of coronary artery bypass grafting in patients with coronary heart disease. Results and discussion. The results of our study show the absence of significant differences in the occurrence of large cardiovascular events between the staged approach in patients with ACS and multivascular disease and CABG in patients with coronary heart disease, which confirms the effectiveness and safety of the staged approach. Conclusion: Surgical myocardial revascularization in the early periods after stenting of the clinically dependent artery in patients with acute coronary syndrome and the multivessel lesion has an advantage over aorta coronary bypass surgery at the combined point of major cardiovascular events.
About the Authors
A. V. Bocharov
Kostroma regional clinical hospital named after Korolev E.I
Tajikistan
Tajikistan
L. V. Popov
National medico-surgical center named after N.I. Pirogov
Tajikistan
Tajikistan
References
1. Бернс, С.А. Факторы, влияющие на развитие летальных исходов у пациентов в течение пяти лет после острого коронарного синдрома без подъема сегмента ST / С.А. Бернс и др. // Неотложная кардиология. - 2017. - №2. - С. 3-12.
2. Меркулов, Е.В., Миронов В.М., Шрейдер Е.В. и др. Чрескожное коронарное вмешательство при стенозе ствола левой коронарной артерии у больных с острым коронарным синдромом: клинические и ангиографические предвестники неблагоприятного прогноза в период госпитализации / Е.В. Меркулов и др. // Неотложная кардиология. - 2014. - №4. - С. 22-36.
3. Кузьмина, Н.М. Влияние поражения ствола левой коронарной артерии на сократительную функцию левого желудочка в отдалённом периоде / Н.М. Кузьмина // Вестник Авиценны. - 2018. - Т. 20. №1. - С. 37-41.
4. Кузьмина, Н.М. Высокотехнологичная медицинская помощь при остром коронарном синдроме в Удмуртской Республике / Н.М. Кузьмина, Н.И. Максимов // Вестник Авиценны. - 2017. - Т. 19. № 1. - С. 37-41.
5. Bonacchi M. Urgent surgical revascularization of unstable angina: influence of double mammary arteries. European Journal of Cardio-Thoracic Surgery, 2001, Vol. 20, pp. 747-754.
6. Braunwald E. Unstable angina. Is it time for a Requiem? Circulation, 2015, Vol. 127, pp. 2452-2457.
7. De Feyter P.J. Bypass surgery versus stenting for the treatment of multivessel disease in patients with unstable angina compared with stable angina. Circulation, 2002, Vol. 105, pp. 2367-2372.
8. Franz-Josef N. 2018 ESC/EACTS Guidelines on myocardial Revascularization. European Heart Journal, 2018, Vol. 40, No. 2, pp. 87-165.
9. Fukui T. Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectors. Journal of Thoracic and Cardiovascular Surgery, 2013, Vol. 145, pp. 1577-1583.
10. Hoffman S. N. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one - to eight - year outcomes. Journal of the American College of Cardiology, 2003, Vol. 41, pp. 1293-1304.
11. Louagie Y. A. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Elevation of the European Society of Cardiology (ESC). European Heart Journal, 2016, Vol. 37, pp. 267-315.
12. Sussenbach C. P. Unstable angina does not increase mortality in coronary artery bypass graft surgery. Revista Brasileira de Cirurgia Cardiovascular, 2013, Vol. 28, pp. 391.
13. Wright R. S. American college of Cardiology Foundation / American Heart Association Task Force on Practice Guidelines 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina / Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation / American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. Journal of the American College of Cardiology, 2011, Vol. 57, pp. e215-e367.
14. Committee for proprietary medicinal products (CPMP) (2004). Points to consider on the choice of non-inferiority margin. - URL: http://home.att.ne.jp/red/ akihiro/emea/215899en_ptc.pdf
15. Food and Drug Administration (FDA) (2016) Non-Inferioty Clinical Trials to Establish Effectiveness. Guidance for Industry. - URL: https://www.fda.gov/downloads/Drugs/Guidances/UCM202140.pdf.
Review
For citations:
Bocharov A.V., Popov L.V. LONG-TERM RESULTS OF STAGE MYOCARDIAL REVASCULARIZATION IN PATIENTS WITH ACUTE CORONARY SYNDROME AND MULTIVESSEL LESION. Health care of Tajikistan. 2020;(1):18-23. (In Russ.)
Views:
242
Email this article 